Lombardia Capital Partners’s AbbVie ABBV Stock Holding History

Lombardia Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-89,067	Closed	-$5.09M	–	197
2016 Q1	$5.09M	Sell	89,067 -103,142	-54%	-$5.75M	0.26%	110
2015 Q4	$11.4M	Sell	192,209 -1,152	-0.6%	-$66.4K	0.57%	65
2015 Q3	$10.5M	Hold	193,361	–	–	0.5%	77
2015 Q2	$13M	Sell	193,361 -184,943	-49%	-$12.1M	0.44%	86
2015 Q1	$22.1M	Buy	378,304 +164,761	+77%	+$9.95M	0.66%	59
2014 Q4	$14M	Buy	213,543 +46,462	+28%	+$2.93M	0.4%	101
2014 Q3	$9.65M	Buy	+167,081	New	+$9.28M	0.29%	134
2014 Q2	–	Sell	-252,198	Closed	-$13M	–	216
2014 Q1	$13M	Sell	252,198 -1,081	-0.4%	-$54.6K	0.35%	104
2013 Q4	$13.4M	Buy	253,279 +38,378	+18%	+$1.89M	0.38%	99
2013 Q3	$9.61M	Sell	214,901 -11,709	-5%	-$519K	0.31%	108
2013 Q2	$9.37M	Buy	+226,610	New	+$9.91M	0.31%	106

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Lombardia Capital Partners's ABBV Position: Q2 2016 in Review

Lombardia Capital Partners sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 89,067 shares — an estimated $5.09M sold.

Lombardia Capital Partners first reported a position in ABBV in Q2 2013 and held it in 11 quarters. The position peaked at $22.1M in Q1 2015. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Lombardia Capital Partners reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
Lombardia Capital Partners sold 89,067 AbbVie shares in Q2 2016, an estimated $5.09M.
Lombardia Capital Partners first reported a position in AbbVie in Q2 2013 and held it in 11 quarters.
Lombardia Capital Partners's AbbVie position peaked at $22.1M in Q1 2015.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Lombardia Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.